Determining the value of genomics in healthcare
- 27 November 2025
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 31 (12) , 4022-4033
Abstract
As genomic sequencing transitions into mainstream healthcare, critically appraising its value is key to informing evidence-based policy, practice and implementation strategies. Assessing the value of genomics is challenging, as traditional evaluation methods and frameworks do not capture many of the outcomes of genomics. This includes the personal value that genomic information provides individuals and family members, and the potential to reuse sequencing data to improve clinical care and drive research. Evaluation is hampered by lack of standardized outcome measures, small sample sizes, and uncertainties arising from the evolving nature of the technology, its applications and associated costs. Complex health system factors further influence real-world utilization and the value of genomic technologies and services within resource-constrained settings. In this Review, we discuss the need for robust yet agile approaches to evaluating genomic technologies that are dynamically informed by real-world data, and we provide examples of emerging methods and best practices. We emphasize the need for a whole-of-system approach and the need to further advance evaluation and implementation methods, to support health systems to sustainably and equitably integrate genomics into clinical care.Keywords
This publication has 174 references indexed in Scilit:
- ClinGen — The Clinical Genome ResourceNew England Journal of Medicine, 2015
- Effectiveness-implementation Hybrid DesignsMedical Care, 2012
- The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics servicesClinical Genetics, 2011
- The EuroGentest Clinical Utility Gene CardsEuropean Journal of Human Genetics, 2010
- Value for Money? Array Genomic Hybridization for Diagnostic Testing for Genetic Causes of Intellectual DisabilityThe American Journal of Human Genetics, 2010
- Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected childrenClinical Genetics, 2009
- Bayesian and classical estimation of mixed logit: An application to genetic testingJournal of Health Economics, 2009
- Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysisGenetics in Medicine, 2008
- What is the clinical utility of genetic testing?Genetics in Medicine, 2006
- Genetic Test Evaluation: Information Needs of Clinicians, Policy Makers, and the PublicAmerican Journal of Epidemiology, 2002